Overview
Daniel Richardson is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Richardson is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Richardson is currently accepting new patients.
His clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles in the study of Acute Myeloid Leukemia (AML).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Joshua Zeidner is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Zeidner is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Zeidner is currently accepting new patients.
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Duke Blood Cancer Center
As a blood cancer specialist and also a palliative care physician, I bring a different focus to cancer care. I’m working hard to improve the treatment experience for patients who are living with blood cancers. By understanding your experience better, we can develop new ways to improve your quality of life, and provide additional support throughout your treatment and beyond. Dr. Leblanc is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Richardson isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Richardson isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Richardson isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Childhood Acute Myeloid LeukemiaDr. Richardson isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Richardson isAdvanced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- LeukemiaDr. Richardson isAdvanced. Learn about Leukemia.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Richardson isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Richardson isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Richardson isExperienced. Learn about Acute Promyelocytic Leukemia.
- Aplastic AnemiaDr. Richardson isExperienced. Learn about Aplastic Anemia.
- Bone Marrow AspirationDr. Richardson isExperienced. Learn about Bone Marrow Aspiration.
- Castleman DiseaseDr. Richardson isExperienced. Learn about Castleman Disease.

